Dmitry Zamoryakhin
Chief Tech/Sci/R&D Officer presso BIODEXA PHARMACEUTICALS PLC
Profilo
Dmitry Zamoryakhin is currently the Chief Scientific Officer at Biodexa Pharmaceuticals Plc since 2021.
Prior to this, he worked as the Chief Medical Officer at Oxford Biomedica Plc from 2018 to 2021 and as the Head-Development Strategy & Intelligence at Grünenthal GmbH from 2016 to 2018.
Dr. Zamoryakhin holds an MBA and a doctorate from Warwick Business School and a doctorate from Perm State Medical University.
Posizioni attive di Dmitry Zamoryakhin
| Società | Posizione | Inizio |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 11/07/2021 |
Precedenti posizioni note di Dmitry Zamoryakhin
| Società | Posizione | Fine |
|---|---|---|
| OXFORD BIOMEDICA PLC | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Corporate Officer/Principal | 01/08/2018 |
Formazione di Dmitry Zamoryakhin
| Warwick Business School | Doctorate Degree |
| Perm State Medical University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
- Borsa valori
- Insiders
- Dmitry Zamoryakhin
